Real World Outcomes in Patients with Advanced Melanoma Treated in Alberta, Canada: A Time-Era Based Analysis

Real World Outcomes in Patients with Advanced Melanoma Treated in Alberta, Canada: A Time-Era Based Analysis

Immune checkpoint and MAP kinase pathway inhibitors can significantly improve long-term survival for patients with melanoma. There is limited real-world data of these regimens’ effectiveness. We retrospectively analyzed 402 patients with unresectable and metastatic melanoma between August 2013 and J...

Full description

Bibliographic Details
Main Authors: Rodrigo Rigo, Jordan Doherty, Kim Koczka, Shiying Kong, Philip Q. Ding, Tina Cheng, Winson Y. Cheung, Jose G. Monzon
Format: Article
Language:English
Published: MDPI AG 2021-10-01
Series:Current Oncology
Subjects:
melanoma
overall survival
ipilimumab
nivolumab
targeted therapy
<i>BRAF</i> mutation
Online Access:https://www.mdpi.com/1718-7729/28/5/338

Similar Items

Similar Items